Drugs / Hongjin Xiaojie Capsules
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT06310538 Comparator | Mar → May 2024 | hyperplasia | Hongguo Rong | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hongjin Xiaojie Capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06310538 ↗ |
| Known as | HongjinXiaojie capsule | “The main group of HongjinXiaojie capsule is divided into anisanglian, Bupleurum, Notoginseng, golden buckwheat, Xiangfu, chicken Yanteng, etc., which has the effect of soft and...” NCT06310538 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Chinese patent medicine treatment” NCT06310538 ↗ |